"
Home Page1 Page2 Page3 Page4 Page5 Page6 Page7 Page8 Page9 Page10 Page11 Page12 Page13 Page14 Page15 Page16 Page17 Page18 Page19 Page20 Page21 Page22 Page23 Page24 Page25 Page26 Page27 Page28 Page29 Page30 Page31 Page32 Page33 Page34 Page35 Page36 Page37 Page38 Page39 Page40 Page41 Page42 Page43 Page44 Page45 Page46 Page47 Page48 Page49 Page50 Page51 Page52 Page53 Page54 Page55 Page56 Page57 Page58 Page59 Page60 Page61 Page62 Page63 Page64 Page65 Page66 Page67 Page68 Page69 Page70 Page71 Page72 Page73 Page74 Page75 Page76 Page77 Page78 Page79 Page80 Page81 Page82 Page83 Page84 Page85 Page86 Page87 Page88 Page89 Page90 Page91 Page92 Page93 Page94 Page95 Page96 Page97 Page98 Page99 Page100 Page101 Page102 Page103 Page104 Page105 Page106 Page107 Page108 Page109 Page110 Page111 Page112 Page113 Page114 Page115 Page116 Page117 Page118 Page119 Page120 Page121 Page122 Page123 Page124 Page125 Page126 Page127 Page128 Page129 Page130 Page131

Cephalosporins: Classification, Mechanism, Uses, and Side Effects

Classification of Cephalosporins

  • First Generation: Cefazolin, Cephalexin - Effective against Gram-positive bacteria and some Gram-negative organisms.
  • Second Generation: Cefuroxime, Cefoxitin - Broader Gram-negative coverage, including *Haemophilus influenzae* and *Moraxella catarrhalis*.
  • Third Generation: Ceftriaxone, Cefotaxime - Increased Gram-negative coverage, including *Pseudomonas aeruginosa* (except ceftriaxone).
  • Fourth Generation: Cefepime - Broad-spectrum with enhanced activity against *Pseudomonas* and Gram-positive organisms.
  • Fifth Generation: Ceftaroline, Ceftobiprole - Effective against MRSA and resistant Gram-negative organisms.

Mechanism of Action

Cephalosporins inhibit bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs) on the bacterial cell membrane. This prevents the cross-linking of peptidoglycan, leading to cell wall rupture and bacterial cell death due to osmotic instability.


Mechanism of Resistance

  • β-lactamase production: Bacteria produce enzymes that break the β-lactam ring of cephalosporins.
  • Alteration of PBPs: Mutations in PBPs reduce their binding affinity to cephalosporins.
  • Decreased drug permeability: Some bacteria decrease the permeability of their outer membrane to prevent drug entry.
  • Efflux pumps: Some bacteria expel cephalosporins from the cell using efflux pumps.

Therapeutic Uses

  • Infections caused by Gram-positive bacteria (e.g., *Staphylococcus* and *Streptococcus*)
  • Respiratory tract infections (e.g., pneumonia, sinusitis, otitis media)
  • Urinary tract infections (e.g., cystitis, pyelonephritis)
  • Surgical prophylaxis
  • Meningitis (third-generation cephalosporins like ceftriaxone)
  • Bone and joint infections
  • Sepsis and febrile neutropenia (for serious hospital-acquired infections)

Adverse Effects

  • Hypersensitivity reactions: Rash, fever, and anaphylaxis in rare cases.
  • Gastrointestinal: Diarrhea, nausea, vomiting.
  • Hematologic: Thrombocytopenia, eosinophilia, neutropenia (rare).
  • Renal: Renal toxicity, especially in high doses and renal impairment.
  • Disulfiram-like reaction: With cefotetan, causing flushing, headache, nausea if alcohol is consumed.
  • Superinfections: Fungal or bacterial overgrowth (e.g., Candida, *Clostridium difficile*).

Contraindications

  • Hypersensitivity: Known allergy to cephalosporins or other β-lactam antibiotics (e.g., penicillins).
  • Renal impairment: Caution or adjusted doses for renal failure patients.
  • Pregnancy: Generally safe (category B), but caution is advised for prolonged use.
  • Lactation: Generally safe for breastfeeding, but monitoring is recommended for prolonged use.


© 2024 Easy Notes on Pharmacology.
Privacy Policy | Contact Us Subscribe to our RSS feed